Pfizer has revealed which three healthtech start-ups will be joining its UK accelerator
The accelerator programme aims to help late-stage businesses get their technology adopted by the NHS within the next 12 months
Global pharmaceutical giant Pfizer has revealed which three UK healthtech start-ups have been accepted onto its London-based accelerator.
Startups 100-ranked Cera, GiveVision and Echo were all selected following a judging day hosted at Pfizer’s UK head office in Tadworth and will now join the Healthtech Hub.
The three businesses will now have access to Pfizer’s expertise and leverage contacts to help get their technology solutions adopted by the NHS – with Pfizer hoping this will be achievable in under 12 months.
Due to the nature of public-funded healthcare in the UK, start-ups have traditionally faced difficulties in persuading the NHS to implement their tech, and thus, access their clients.
As a result, a majority of UK healthtech startups focus their efforts in the US at an earlier stage compared to other sectors.
Founded by former NHS advisor Dr. Mahiben Maruthappu and Marek Sacha, Cera is a digital homecare platform that helps users pick the right carer for loved ones with illnesses such as dementia, Parkinson’s disease, learning difficulties and cancer.
App-based platform Echo allows users to manage their medication and ensure their repeat prescriptions are delivered straight to their door by first class Royal Mail. Free to use, the app also reminds users when to visit their GP and even what time to take their medicine.
While GiveVision offers the visually impaired a wearable headset called SightPlus – which aims to improve their sight.
Speaking to Techworld, Dr Hamish Graham, a practicing surgeon and London manager for the Pfizer Healthcare Hub, said:
“You have to understand their language if you want to get your tech adopted there. You have to understand their priorities and it is a challenge for a lot of start-ups.
“They can be fluent in their coding, product development and put a great team together but they then struggle to expand to hospital two, three and four, because they need to communicate their value in a way that a manager can understand it.
“At the end of 12 months that’s how we know if we have done a good job. Are there people using it? We’ve got no other KPIs.”